Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alphanate ITI in Congenital Hemophilia A
NCT03095287Phase 2Terminated
- Sponsor
- Grifols
- Start
- Jan 2018
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 2 trial of coagulation factor IX human in hemophilia A, sponsored by Grifols. Started Jan 2018; status: terminated.
02
Drugs
coagulation factor IX human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT03095287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03095287.